KYMR
Price
$43.87
Change
+$0.12 (+0.27%)
Updated
Aug 1, 10:38 AM (EDT)
Capitalization
3.07B
Earnings call today
PROK
Price
$2.65
Change
-$0.12 (-4.33%)
Updated
Aug 1, 10:50 AM (EDT)
Capitalization
371.57M
6 days until earnings call
Interact to see
Advertisement

KYMR vs PROK

Header iconKYMR vs PROK Comparison
Open Charts KYMR vs PROKBanner chart's image
Kymera Therapeutics
Price$43.87
Change+$0.12 (+0.27%)
Volume$100
Capitalization3.07B
ProKidney
Price$2.65
Change-$0.12 (-4.33%)
Volume$2.93K
Capitalization371.57M
KYMR vs PROK Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. PROK commentary
Aug 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 01, 2025
Stock price -- (KYMR: $43.78 vs. PROK: $2.79)
Brand notoriety: KYMR and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 44% vs. PROK: 21%
Market capitalization -- KYMR: $3.07B vs. PROK: $371.57M
KYMR [@Biotechnology] is valued at $3.07B. PROK’s [@Biotechnology] market capitalization is $371.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $223.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 3 bearish.
  • PROK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than PROK.

Price Growth

KYMR (@Biotechnology) experienced а -4.51% price change this week, while PROK (@Biotechnology) price change was -14.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.13%. For the same industry, the average monthly price growth was +16.53%, and the average quarterly price growth was +40.85%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-1.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.07B) has a higher market cap than PROK($372M). PROK YTD gains are higher at: 64.793 vs. KYMR (8.824). PROK has higher annual earnings (EBITDA): -160.12M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. PROK (328M). PROK has less debt than KYMR: PROK (3.37M) vs KYMR (86.3M). KYMR has higher revenues than PROK: KYMR (58.9M) vs PROK (306K).
KYMRPROKKYMR / PROK
Capitalization3.07B372M826%
EBITDA-232.67M-160.12M145%
Gain YTD8.82464.79314%
P/E RatioN/AN/A-
Revenue58.9M306K19,248%
Total Cash463M328M141%
Total Debt86.3M3.37M2,562%
TECHNICAL ANALYSIS
Technical Analysis
KYMRPROK
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
61%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 8 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWPYX21.96N/A
N/A
AB Sustainable Intl Thematic Advisor
TEMFX9.02N/A
N/A
Templeton Foreign A
LKSCX21.89N/A
N/A
LKCM Small Cap Equity Instl
QISOX13.09N/A
N/A
Pear Tree Polaris Intl Opps Ord
RGLEX26.40-0.15
-0.56%
American Funds Global Insight R-4

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.66%
NRIX - KYMR
67%
Closely correlated
-5.22%
VERA - KYMR
59%
Loosely correlated
-1.47%
CGON - KYMR
56%
Loosely correlated
+2.57%
LYRA - KYMR
54%
Loosely correlated
-4.30%
IDYA - KYMR
53%
Loosely correlated
-3.94%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with LGVN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then LGVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+3.53%
LGVN - PROK
43%
Loosely correlated
+3.04%
NRIX - PROK
39%
Loosely correlated
-5.22%
APGE - PROK
38%
Loosely correlated
+1.73%
CGEM - PROK
37%
Loosely correlated
-4.90%
KYMR - PROK
37%
Loosely correlated
-0.66%
More